Fig. 4

The plasma level of cytokines and C3 in Heymann nephritis rats and those after hESC-IMRC treatments. The plasma level of IL-10 (a) was increased in both groups of lower-dose (T1) and high-dose (T2) of IMRC treatments. The plasma level of IL-17A, TNF-α, and C3 was decreased in both groups (b, c, e). The plasma level of IL-2, IL-4, IL-6 was comparable among the four groups (d). *P < 0.05; **P < 0.01; ***P < 0.001